World Point Terminals, LP (the “Partnership”), a Delaware limited
partnership (NYSE: WPT), announced today that the board of directors of
its general partner declared a cash distribution of $0.30 per unit
($1.20 per unit on an annualized basis) for the period from October 1,
2014 through December 31, 2014.
M2M and IoT are transforming industries and creating tremendous opportunities for mobile M2M module vendors around the world
CAMPBELL, CA--(Marketwired - January 15, 2015) - Technology market research firm Infonetics Research , now part of IHS Inc. (NYSE: IHS), today released excerpts from its latest Mobile M2M Modules report, which provides market share, market size, forecasts, analysis and trends for mobile machine-to-machine (M2M) modules by technology, vertical and region.
Citizens Financial Group (NYSE: CFG) announced today that Chairman and
Chief Executive Officer Bruce Van Saun will present at the 16 th
Annual Credit Suisse Financial Services Forum on Tuesday, February 10,
2015 at 2:30 p.m. ET.
- In Phase 3 clinical trials, VIEKIRAX + EXVIERA cured 95-100 percent of genotype 1 chronic hepatitis C patients, with less than 2 percent of patients experiencing virologic failure,
- Tolerability profile shows more than 98 percent of patients completed a full course of therapy - All-oral, interferon-free regimen also approved for HCV/HIV-1 co-infection, patients on opioid substitution therapy and patients who have undergone a liver transplant, - VIEKIRAX + EXVIERA are the first products to be approved as a combination treatment of three direct-acting antivirals with distinct mechanisms of action targeting hepatitis C at multiple steps in the viral lifecycle, NORTH CHICAGO, Ill.
Sign-up for European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Chronic Hepatitis C investment picks
MONTREAL, QUEBEC and QUEBEC CITY, QUEBEC --
NEW YORK, NY--(Marketwired - January 15, 2015) - JetBlue Airways Corporation (NASDAQ: JBLU) announced today that it will hold its quarterly conference call to discuss fourth quarter and full year 2014 financial results on January 29, 2015 at 10:00 a.m. ET.
The Wet Seal, Inc. (Nasdaq: WTSL), a specialty retailer to young women,
today announced that it has filed voluntary petitions for relief under
Chapter 11 of the United States Bankruptcy Code in the United States
Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”)
on January 15, 2015.
Enanta Announces European Commission Grants Marketing Authorizations
for AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) +
EXVIERA® (dasabuvir tablets) for the Treatment of Genotypes 1 and 4
Chronic Hepatitis C Virus
Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and
development-focused biotechnology company dedicated to creating small
molecule drugs for viral infections and liver diseases, today announced
that the European Commission has granted marketing authorizations for
AbbVie’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) +
EXVIERA® (dasabuvir tablets) 1,2 with or without ribavirin
(RBV) for the treatment of patients with genotype 1 (GT1) chronic
hepatitis C virus (HCV) infection, including those with compensated
liver cirrhosis, HIV-1 co-infection, patients on opioid substitution
therapy and liver transplant recipients.
Full-Year 2014 Net Income of $593 Million, or $3.16 Per Share Broad-Based Loan and Deposit Growth Compared to Full-Year 2013 Average Loans Up $2.2 Billion, or 5 Percent
Average Deposit Growth of $3.1 Billion, or 6 Percent Drive for Efficiency Demonstrated in Well-Controlled Expenses Credit Quality Remains Strong 5.2 Million Shares Repurchased in 2014 Under the Share Repurchase Program; $392 Million or 66 Percent of 2014 Net Income Returned to Shareholders DALLAS , Jan.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.